8-K: Grown Rogue Reports Strong Q2 Growth, Raises Guidance

Grown Rogue International Inc. announced a 41% year-over-year revenue increase to $11.3 million for Q2 2026, alongside raised full-year and 2027 financial guidance.

Summary

• Grown Rogue reported Q2 2026 revenue of $11.3 million, a 41% increase from $8.0 million in Q2 2025, driven by strong performance in New Jersey (65% growth), Michigan (49% growth), and Oregon (14% growth).
• Adjusted EBITDA was $2.1 million with an 18.2% margin, up from $1.5 million and 18.9% in the prior year period.
• The company reported a GAAP net loss of $1.5 million for the quarter, impacted by $0.8 million in non-cash fair-value losses on derivative and warrant instruments.
• Grown Rogue ended the quarter with $11.5 million in cash and cash equivalents.
• Expansion projects in New Jersey, Illinois, and Minnesota are progressing, with Illinois cultivation operational and Minnesota construction ongoing.
• The company raised its 2026 revenue guidance to $38-$41 million (from $34-$37 million) and its 2026 Adjusted EBITDA guidance to $7-$9 million (from $6-$8 million).
• 2027 revenue guidance was also increased to $55-$63 million (from $50-$58 million).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth and increased guidance, though the net loss and ongoing expansion costs are noted.

Positives

• Revenue increased by 41% year-over-year to $11.3 million in Q2 2026.
• New Jersey operations saw a 65% revenue increase, Michigan 49%, and Oregon 14%.
• Adjusted EBITDA grew by 36% to $2.1 million, with a margin of 18.2%.
• Cash and cash equivalents increased to $11.5 million, providing financial flexibility.
• Significant progress in expansion projects in New Jersey, Illinois, and Minnesota.
• 2026 revenue guidance increased to $38-$41 million.
• 2026 Adjusted EBITDA guidance increased to $7-$9 million.
• 2027 revenue guidance increased to $55-$63 million.

Negatives

• Reported a GAAP net loss of $1.5 million for Q2 2026, compared to a net income of $1.7 million in the prior-year period.
• Q2 2026 results included approximately $0.8 million in net non-cash fair-value losses related to derivative and warrant instruments.
• Michigan's Adjusted EBITDA margin decreased to 20.0% (22.7% excluding excise tax) from 26.8% in Q2 2025.
• Corporate Adjusted EBITDA was a loss of $1.2 million, an increase from $0.8 million in the prior year period.

Risks

• Changes in general economic, business, political and financial-market conditions.
• Changes in cannabis laws, regulations or enforcement policies.
• The continued illegality of cannabis under United States federal law.
• Declines or volatility in wholesale cannabis pricing and demand.
• Increased competition.
• Variations in cultivation yields, product quality and production costs.
• Construction, commissioning or ramp-up delays and cost overruns.
• The Company's ability to generate sufficient cash flow or obtain financing on acceptable terms.

Future Outlook

The company has increased its 2026 revenue guidance to $38-$41 million and Adjusted EBITDA guidance to $7-$9 million. 2027 revenue guidance is also raised to $55-$63 million. Expansion projects in Illinois and Minnesota are expected to contribute revenue in late 2026 and early 2027, respectively. The New Jersey expansion is expected to contribute more fully in 2027.

Management Comments

• "The second quarter reflected our continued focus on disciplined execution in our existing markets while expanding our platform to serve more customers across the US."
• "2026 has been a big year of growth for us as we work to complete the New Jersey expansion, ramp our newly activated production facility in Illinois, and finish construction and begin operations in Minnesota."
• "From a financial standpoint, New Jersey continues to demonstrate the value of pairing quality flower with disciplined execution in a higher priced market."
• "In Oregon and Michigan, our KPIs show continued strong performance in cultivation operations, and it's great to see modest pricing improvements rewarding our discipline in these hyper-competitive environments."
• "We are building a foundation of people and systems that can travel across markets without losing the quality and consistency that define Grown Rogue."
• "Excluding the Michigan excise tax, second quarter results reflected 36% year-over-year revenue growth to $11.3 million and a 36% increase in Adjusted EBITDA to $2.1 million."
• "Based on our second quarter performance and current expectations for the balance of the year, we are updating our 2026 and 2027 guidance."
• "Minnesota represents a purpose-built new-market opportunity, while Illinois represents a capital-efficient turnaround of existing infrastructure."

Industry Context

StockSavvy.ai notes that Grown Rogue's performance aligns with a trend of consolidation and expansion within the cannabis industry, where companies are focusing on operational efficiency and market penetration in key states. The increased guidance reflects confidence in executing growth strategies despite market volatility.

Comparison to Industry Standards

• The reported revenue growth of 41% in Q2 2026 is significantly higher than the average growth rates seen in many mature cannabis markets, which are often in the single to low double digits.
• Adjusted EBITDA margins of 18.2% are competitive within the industry, though some vertically integrated operators in less competitive markets may achieve higher margins.
• The company's expansion into new states like Illinois and Minnesota mirrors strategies employed by other multi-state operators (MSOs) seeking to diversify and capture market share.
• Focus on 'flower-forward' products and branded offerings is a common strategy to differentiate and capture premium pricing, as seen with companies like Curaleaf and Trulieve, though Grown Rogue emphasizes its 'craft values'.

Stakeholder Impact

• Shareholders: Potential for increased value due to raised guidance and expansion success, but offset by current net loss and market risks.
• Employees: Growth in operations may lead to job creation, particularly in expansion states.
• Customers: Continued availability of branded, quality cannabis products across multiple markets.
• Suppliers: Increased demand for cultivation inputs and operational services.
• Creditors: Improved financial performance and cash position may strengthen creditworthiness.

Next Steps

• Complete New Jersey expansion by Q4 2026.
• Ramp up production and sales in Illinois, with initial sales expected in Q4 2026.
• Begin operations in Minnesota, with first revenue expected in Q1 2027.
• Launch single-source cured-resin vape products in Michigan and New Jersey later in 2026.
• Launch infused pre-rolls in New Jersey before year-end 2026.
• Expand Illinois flowering canopy from 5,000 to 14,000 sq. ft. in mid-2027.
• Expand Minnesota flowering canopy from 8,000 to approximately 16,000 sq. ft. in mid-2027.

Key Dates

Recommendation

The company demonstrates strong execution with significant revenue growth and increased guidance, particularly in key expansion markets. However, the continued GAAP net loss, impact of non-cash items, and inherent risks in the cannabis industry warrant a cautious 'hold' rating until profitability is consistently achieved and expansion projects fully mature.

Keywords

cannabis, revenue growth, Adjusted EBITDA, New Jersey, Illinois, Minnesota, cultivation, guidance